Subconjunctival chemotherapeutic delivery by fibrin sealant in the treatment of retinoblastoma
AssigneesBaxter Internationalinc., Baxter Healthcare S.A.
InventorsChristopher Ray HIMES, Timothy M. FULGHUM
Life of this patent
Estimating the term…
Abstract
Methods and compositions for treating retinoblastoma are disclosed. The methods comprise administering a composition comprising two or more chemotherapeutic agents and a fibrin sealant material to a patient in need thereof. The compositions comprise two or more chemotherapeutic agents and a fibrin sealant material. Also disclosed are dual-compartment syringes comprising two or more chemotherapeutic agents, fibrinogen, and thrombin.
Claims41
A method for treating retinoblastoma comprising:
- administering a composition comprising two or more chemotherapeutic agents and a fibrin sealant material to a patient in need thereof.
A composition for treating retinoblastoma comprising:
- two or more chemotherapeutic agents and a fibrin sealant material.
A dual-compartment syringe comprising two or more chemotherapeutic agents, fibrinogen, and thrombin.
Dependencies are inferred from the claim text.